[go: up one dir, main page]

AU2003301758A1 - Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders - Google Patents

Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders

Info

Publication number
AU2003301758A1
AU2003301758A1 AU2003301758A AU2003301758A AU2003301758A1 AU 2003301758 A1 AU2003301758 A1 AU 2003301758A1 AU 2003301758 A AU2003301758 A AU 2003301758A AU 2003301758 A AU2003301758 A AU 2003301758A AU 2003301758 A1 AU2003301758 A1 AU 2003301758A1
Authority
AU
Australia
Prior art keywords
manifacture
hyper
medicament
treatment
proliferative disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003301758A
Other versions
AU2003301758A8 (en
Inventor
Jianqing Chen
Yuanwei Chen
Barry Hart
Jill E. Wood
Lin Yi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharmaceuticals Corp
Original Assignee
Bayer Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals Corp filed Critical Bayer Pharmaceuticals Corp
Publication of AU2003301758A8 publication Critical patent/AU2003301758A8/en
Publication of AU2003301758A1 publication Critical patent/AU2003301758A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003301758A 2002-05-06 2003-05-02 Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders Abandoned AU2003301758A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37833002P 2002-05-06 2002-05-06
US60/378,330 2002-05-06
PCT/US2003/013784 WO2004039359A2 (en) 2002-05-06 2003-05-02 Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders

Publications (2)

Publication Number Publication Date
AU2003301758A8 AU2003301758A8 (en) 2004-05-25
AU2003301758A1 true AU2003301758A1 (en) 2004-05-25

Family

ID=32230080

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003301758A Abandoned AU2003301758A1 (en) 2002-05-06 2003-05-02 Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders

Country Status (2)

Country Link
AU (1) AU2003301758A1 (en)
WO (1) WO2004039359A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI329105B (en) * 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
MXPA05001096A (en) 2002-07-29 2005-11-23 Rigel Pharmaceuticals Inc Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds.
AU2004265288A1 (en) 2003-07-30 2005-02-24 Rigel Pharmaceuticals, Inc. 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
US7557207B2 (en) 2004-11-24 2009-07-07 Rigel Pharmaceuticals, Inc. Spiro 2,4-pyrimidinediamine compounds and their uses
CN101115761B (en) 2005-01-19 2012-07-18 里格尔药品股份有限公司 Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0004890D0 (en) * 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds

Also Published As

Publication number Publication date
AU2003301758A8 (en) 2004-05-25
WO2004039359A2 (en) 2004-05-13
WO2004039359A3 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
AU2003286567A1 (en) Methods for the treatment of skin disorders
AU2003282679A1 (en) Hydroxypyrazoles for use against metabolic-related disorders
AU2003224725A1 (en) Hiv therapeutic
AU2003295763A1 (en) Medical devices
AU2003220647A1 (en) Medical devices
AU2003289997A1 (en) Inhalation therapy device
AU2003275266A1 (en) Therapeutic compounds based on pyrazolopyridine derivatives
AU2003300791A1 (en) Combination therapy for the treatment of pain
AU2003286728A1 (en) Compounds for the treatment of metabolic disorders
PT1487828E (en) Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
AU2003258145A1 (en) Substituted phenylindoles for the treatment of hiv
AU2003251904A1 (en) Combinations of drugs for the treatment of neoplasms
AU2003247005A1 (en) Therapy combination
AU2003244638A1 (en) Inhalation therapy device
AU2003245794A1 (en) Glycosaminoglycan-dnase combination therapy
AU2003215150A1 (en) Therapeutic compounds
AU2003205898A1 (en) Combination therapy for respiratory disorders
AU2003301758A1 (en) Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders
AU2003296545A1 (en) Use of a trpm8-activating substance for the treatment of tumours
AU2003237460A1 (en) Combination treatments for purinoceptor-related disorders
AU2003209542A1 (en) Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders
AU2003269257A1 (en) Use of cap-1 for the therapy of asthma
AU2003274885A1 (en) Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders
AU2003256491A1 (en) Furopyridine and furopyrimidine derivatives for the treatment of hyper-proliferative disorders
GB0201025D0 (en) The treatment of degenerative diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase